Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest fool.com · about 12 hours ago

AST SpaceMobile vs. Rocket Lab: Which Space-Based Network Stock Is a Better Buy in 2026?

AST SpaceMobile is building the first space-based cellular network designed to work with standard, unmodified smartphones. Rocket Lab is a vertically integrated space company that combines a proven launch record with a growing satellite systems business.

Stocks

More recent coverage

Page 20
ALHC globenewswire.com · about 12 hours ago

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Continues Following Whistleblower Lawsuit Of Financial Manipulation

LOS ANGELES, July 31, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) on behalf of investors concerning the Company's possible violations of federal securities laws after the stock price fell 16% on July 8, 2026.

RITM seekingalpha.com · about 12 hours ago

Rithm Capital: The Dividend Looks Safer Than The Stock Price Suggests

Rithm Capital Corp. delivered strong Q2 distributable earnings, covering its $0.25 dividend by 2.4x and supporting a Buy rating. RITM trades at about 0.8x book value, with the market underappreciating its platform diversification beyond traditional mortgage REIT activities. Asset management AUM rose to $61B, and business lines like Newrez and Genesis showed momentum, strengthening the investment case.

EPSN globenewswire.com · about 12 hours ago

Epsilon Energy Ltd. Schedules Second Quarter 2026 Earnings Release and Conference Call

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its second quarter 2026 earnings release on Wednesday, August 12, 2026 after the market close and host a conference call to discuss its financial and operating results on Thursday, August 13, 2026 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time).

IRON globenewswire.com · about 12 hours ago

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.

HTD prnewswire.com · about 12 hours ago

JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

BOSTON, July 31, 2026 /PRNewswire/ -- John Hancock Tax-Advantaged Dividend Income Fund (NYSE: HTD) (the "Fund"), a closed-end fund managed by John Hancock Investment Management LLC and subadvised by Manulife Investment Management (US) LLC, announced today sources of its monthly distribution of $0.1580 per share paid to all shareholders of record as of July 13, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission.

CAPR globenewswire.com · about 12 hours ago

CAPR INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Capricor Therapeutics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

ATLANTA, July 31, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor”) (NASDAQ: CAPR). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Capricor adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel; (2) the FDA had not agreed to those changes before Capricor resubmitted the Deramiocel Biologics License Application; (3) as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of Deramiocel; and (4) as a result of the foregoing, there was a substantial risk to regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy.

MSFT globenewswire.com · about 12 hours ago

MSFT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Microsoft Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – MSFT

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Microsoft Corporation (NASDAQ: MSFT) between May 1, 2025 and January 28, 2026, inclusive (the “Class Period”), of the important August 11, 2026 lead plaintiff deadline.

GTLL newsfilecorp.com · about 12 hours ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hertz Global Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HTZ

New York, New York--(Newsfile Corp. - July 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Hertz Global Holdings, Inc. (NASDAQ: HTZ) between May 7, 2026 and June 23, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

AMZN youtube.com · about 12 hours ago

Amazon Has Best Day Since 2012 | Closing Bell

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Emily Graffeo, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?

PDT prnewswire.com · about 12 hours ago

JOHN HANCOCK PREMIUM DIVIDEND FUND NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)

BOSTON, July 31, 2026 /PRNewswire/ -- John Hancock Premium Dividend Fund (NYSE: PDT) (the "Fund"), a closed-end fund managed by John Hancock Investment Management LLC and subadvised by Manulife Investment Management (US) LLC, announced today sources of its monthly distribution of $0.0883 per share paid to all shareholders of record as of July 13, 2026, pursuant to the Fund's managed distribution plan. This press release is issued as required by an exemptive order granted to the Fund by the U.S. Securities and Exchange Commission.

PODD newsfilecorp.com · about 12 hours ago

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PODD

New York, New York--(Newsfile Corp. - July 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important August 31, 2026 lead plaintiff deadline. SO WHAT: If you purchased Insulet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

← Newer
Older →